Pharmacy Freak Editorial Team

Introduction: This quiz set on “Legislation and regulations for cosmetics in US & Canada” is tailored for M.Pharm students studying Regulatory Aspects of Drugs & Cosmetics (MRA201T). It covers statutes, regulatory authorities, labeling and ingredient requirements, premarket controls, classification issues (cosmetic vs drug), adverse event reporting, import/export controls, and enforcement mechanisms in both jurisdictions. The … Read more

Regulatory considerations for manufacturing, packaging and labeling in US MCQs With Answer This quiz set is designed for M.Pharm students studying Regulatory Aspects of Drugs & Cosmetics (MRA201T) and focuses on US regulatory requirements for manufacturing, packaging and labeling. Questions emphasize current Good Manufacturing Practices (cGMP), 21 CFR requirements, labeling rules, packaging controls, serialization, stability, … Read more

This quiz collection is designed for M.Pharm students preparing for the Regulatory Aspects of Drugs & Cosmetics (MRA201T) exam. It focuses on regulatory requirements for orphan drugs and combination products, clarifying key definitions, designation criteria, incentive mechanisms, submission pathways, and post‑market obligations. The questions are crafted to deepen understanding of orphan designation processes (US and … Read more

Introduction This quiz set focuses on regulatory approval processes in the United States — IND, NDA, ANDA and SNDA — tailored for M. Pharm students preparing for Regulatory Aspects of Drugs & Cosmetics (MRA201T). It covers definitions, application types, review timelines, exclusivities, patent certifications under Hatch‑Waxman, bioequivalence concepts, and FDA enforcement tools such as clinical … Read more

Introduction: Drug Master Files (DMFs) are central to regulatory submissions in the US when manufacturers need to protect confidential chemistry, manufacturing and controls (CMC) information while allowing drug applicants to reference that information in their applications. This quiz-focused blog presents targeted multiple-choice questions designed for M.Pharm students studying Regulatory Aspects of Drugs & Cosmetics. The … Read more

Introduction: The Hatch-Waxman Act and the FDA’s Orange Book and Purple Book are foundational to modern pharmaceutical regulation and generic/biosimilar competition. This blog presents focused multiple-choice questions to help M.Pharm students master how the Hatch-Waxman framework created the ANDA pathway, paragraph certifications, patent litigation triggers and exclusivity mechanisms. It also clarifies the Orange Book’s role … Read more

Introduction: This quiz set focuses on the history and evolution of the United States Federal Food, Drug, and Cosmetic (FD&C) Act and its related laws, designed for M.Pharm students studying regulatory affairs. It traces key statutes, amendments and landmark decisions that shaped modern drug, device and food regulation — from the Pure Food and Drug … Read more

Introduction: The Federal Register and the Code of Federal Regulations (CFR) are central to understanding how U.S. federal regulatory policy affects pharmaceuticals. For M.Pharm students, mastery of these resources clarifies how rules are proposed, finalized, codified, and enforced—impacting drug approval, labeling, manufacturing, and post-market actions. This blog presents focused multiple-choice questions to reinforce concepts such … Read more

Introduction: The US and Canadian regulatory frameworks are essential knowledge for M.Pharm students preparing to work in drug development, regulatory affairs, or quality assurance. This set of MCQs focuses on the organization and responsibilities of the US Food and Drug Administration (FDA) and the parallel regulatory bodies in Canada, highlighting key legislations, application types (IND, … Read more

Overview of drug development and regulatory landscape for drugs and cosmetics MCQs With Answer This set of multiple-choice questions is designed for M.Pharm students studying Regulatory Aspects of Drugs & Cosmetics (MRA201T). It emphasizes the full life-cycle of pharmaceuticals and cosmetics — from discovery, preclinical and clinical development, to regulatory submissions, approvals, post‑marketing surveillance, and … Read more